Jamie W. Rhoads
( out of 313 reviews )

Jamie W. Rhoads, MD

Languages spoken: English

Clinical Locations

Midvalley Health Center Dermatology

Dermatology
Murray
801-581-2955

Veterans Administration Medical Center

Dermatology Clinic
Salt Lake City
801-582-1565

  • Dr. Jamie Rhoads is board certified in dermatology and completed a 2-year fellowship in psoriasis. She specializes in inpatient dermatology and complex medical dermatology, particularly autoimmune skin disease.

    Specialties

    Board Certification

    National Board of Medical Examiners

    Patient Rating

    4.9 /5
    ( out of 313 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    January 24, 2025
    MIDVALLEY

    Thorough,knowledgeable, and kind

    January 19, 2025
    MIDVALLEY

    Absolutely one of the best physicians I've ever had bar none.

    January 05, 2025
    MIDVALLEY

    I'm just so relieved to have a doctor of this caliber handling my case. She has a great bedside manner. Trust her expertise.

    December 20, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    She very good dr

    December 12, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    She is a GREAT Dr. Knowledgeable, Patient Oriented.

    November 23, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Dr Rhoads saved me from melanoma advancement. She is the best

    November 22, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Superior to all others I have tried

    November 15, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    She very good

    November 14, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Dr. Rhoads is very approachable and takes time to get to know her patients. She works hard to find answers in treatments that will work for you and your individual needs. It's obvious she cares about what she does and how she can help her patients have better quality of life with their skin health.

    See More Patient Comments

  • Dr. Jamie Rhoads is board certified in dermatology and completed a 2-year fellowship in psoriasis. She specializes in inpatient dermatology and complex medical dermatology, particularly autoimmune skin disease.

    Board Certification and Academic Information

    Academic Departments Dermatology -Associate Professor (Clinical)
    Board Certification
    National Board of Medical Examiners

    Education history

    Residency Dermatology - University of Utah Resident
    Graduate Training Clinical Investigation - University of Utah M.S.C.I
    Research Fellow Dermatology - University of Utah Research Fellow
    Internship Internal Medicine - University of Florida College of Medicine-Jacksonville Intern
    Professional Medical Medicine - University of Florida College of Medicine M.D.
    Undergraduate Majors: Chemistry, Biochemistry; Minors: Biology, Math - Florida State University B.S.

    Selected Publications

    Journal Article

    1. Stone CJ, Broadbent E, Sahni VN, Gray L, Clarke JT, Hansen CB, Rhoads JLW, Zone JJ, Hull CM, Wu YP, Kean J, Secrest AM, Hopkins ZH (2025). Use of the Connor-Davidson Resilience Scale in a complex medical dermatology clinic: Cross-sectional study evaluating associations between resilience, health-related quality of life, and mental health. J Am Acad Dermatol. (Read full article)
    2. Eichenfield DZ, Knapp KD, Claxton A, Munoz B, Crawford JM, Balu S, Kim Y, Schneider S, Haft MA, Silverberg JI, Thaci D, Eichenfield LF, Bagel J, Rhoads JW, Paller AS, TARGET-DERM AD Investigators (2025). Unmet Needs of Effective Advanced Systemic Therapies in Moderate-to-Severe Atopic Dermatitis Patients in the TARGET-DERM AD Registry. Dermatitis. (Read full article)
    3. Rhoads JLW, Lavasani L, Rasouliyan L, Laouri M, Noe M (2025). Real-world clinical characteristics and treatment patterns of generalized pustular psoriasis flares. J Am Acad Dermatol. (Read full article)
    4. Noe MH, Lavasani L, Rasouliyan L, Laouri M, Rhoads JLW (2025). Healthcare Resource Utilization Among Patients With Generalized Pustular Psoriasis: The Impact of Flares and Disease Severity. J Psoriasis Psoriatic Arthritis, 24755303251317193. (Read full article)
    5. Sahni V, Teames C, Seifert R, Conley M, deShazo R, Powell D, Rhoads JLW, Clarke JT, Hansen CB, Zone JJ, Hull CM, Hopkins ZH (2025). The association between skin allergy testing and oral squamous cell carcinoma in oral lichen planus: a retrospective cohort study. Arch Dermatol Res, 317(1), 207. (Read full article)
    6. Rhoads JLW, Christensen L, Westerdahl S, Stevens V, Chapman WW, Conway M (2024). Automatic Extraction of Skin and Soft Tissue Infection Status from Clinical Notes. Stud Health Technol Inform, 310, 579-583. (Read full article)
    7. Rhoads JLW, Malatestinic WN, Burge R, Ganz ML, Duffin KC (2023). Factors Associated with Treatment Escalation for Psoriasis: An Analysis of Electronic Health Records Data. J Psoriasis Psoriatic Arthritis, (0).
    8. Snyder AM, Taliercio VL, Rich BE, Brandenberger AU, Webber LB, Biber JE, Hess R, Rhoads JL, Secrest AM (2023). Quality of Life and Avoiding Triggers of Atopic Dermatitis Flares: A Qualitative Study. Skinmed, 21(4), 233-235. (Read full article)
    9. Hopkins ZH, Jimenez A, Taliercio VL, Clarke JT, Hansen CB, Hull CM, Rhoads JLW, Zone JJ, Sahni VN, Kean J, Secrest AM (2023). Skin-Related Quality of Life During Autoimmune Bullous Disease Course. JAMA Dermatol, 159(11), 1185-1194. (Read full article)
    10. Snyder AM, Taliercio VL, Brandenberger AU, Rich BE, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest AM (2023). Atopic Dermatitis: A Qualitative Study on the Burdens of Living with Itchiness. J Clin Aesthet Dermatol, 16(7), 22-25. (Read full article)
    11. Bolender CM, Jimenez A, Clarke JT, Willson TM, Stevens VW, Rhoads JLW (2022). Incidence of Dermatomyositis in a Nationwide Cohort Study of US Veterans. JAMA Dermatol, 158(11), 1321-1323. (Read full article)
    12. Snyder AM, Brandenberger AU, Taliercio VL, Rich BE, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest AM (2022). Quality of Life Among Family of Patients with Atopic Dermatitis and Psoriasis. Int J Behav Med, 30(3), 409-415. (Read full article)
    13. Skemp-Dymond G, Lebiedz-Odrobina D, Zuromski LM, Rhoads JLW, Tebo AE (2021). Assessment of a line immunoassay for the detection of mi-2 antibodies. Am J Clin Pathol, 157, 506-509. (Read full article)
    14. Snyder AM, Taliercio VL, Brandenberger AU, Rich BE, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest AM (2021). Effects of Pain From Atopic Dermatitis: Interview and Focus Group Study With Patients and Their Families. JMIR Dermatol, 4(2), e29826. (Read full article)
    15. Flint ND, Rhoads JLW, Carlisle R, Ferrel M, Hopkins ZH, Secrest AM (2021). The continued inappropriate use and overuse of combination topical clotrimazole-betamethasone. Dermatol Online J, 27(8). (Read full article)
    16. Beshay A, Petersen M, Rhoads JLW (2021). Severe EGFR inhibitor-induced acneiform eruption responding to dapsone. Dermatol Online J, 27(7). (Read full article)
    17. Taliercio VL, Snyder AM, Webber LB, Langner AU, Rich BE, Beshay AP, Ose D, Biber JE, Hess R, Rhoads JLW, Secrest AM (2021). The disruptiveness of itchiness from psoriasis: A qualitative study of the impact of a single symptom on quality of life. J Clin Aesthet Dermatol, 14(6), 42–48.
    18. Taliercio VL, Snyder AM, Webber LB, Langner AU, Rich BE, Beshay AP, Ose D, Biber JE, Hess R, Rhoads JLW, Secrest AM (2021). The disruptiveness of itchiness from psoriasis: A qualitative study of the impact of a single symptom on quality of life. J Clin Aesthet Dermatol, 14(6), 42-48. (Read full article)
    19. Snyder AM, Taliercio VL, Brandenberger AU, Rich BE, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest AM (2021). Effects of pain from atopic dermatitis: Interview and focus group study with patients and their families. JMIR Dermatol, 4(2).
    20. Rhoads JLW, Willson TM, Sutton JD, Spivak ES, Samore MH, Stevens VW (2019). Epidemiology, Disposition, and Treatment of Ambulatory Veterans With Skin and Soft Tissue Infections. Clin Infect Dis, 72(4), 675-681. (Read full article)
    21. Walsh JA, McFadden M, Woodcock J, Clegg DO, Helliwell P, Dommasch E, Gelfand JM, Krueger GG, Duffin KC (2013). Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort. J Am Acad Dermatol, 69(6), 931-7. (Read full article)
    22. Duffin KC, Woodcock J, Krueger GG (2010). Genetic variations associated with psoriasis and psoriatic arthritis found by genome-wide association. Dermatol Ther, 23(2), 101-13. (Read full article)

    Case Report

    1. Dao DP, Sahni VN, Sahni DR, Abbott J, Rhoads JLW (2021). Vasculitis with granulomatosis: An atypical presentation of giant cell arteritis. JAAD Case Rep, 16, 124-126. (Read full article)
    2. Lo MC, Woodcock JL (2011). Case of EBV-induced adrenal insufficiency, cardiac tamponade, and pleural effusions. Fed Pract, 28(7), 23-27.

    Letter

    1. Seifert RM, Hull CM, deShazo RA, Powell DL, Rhoads JLW, Zone JJ, Hopkins ZH (2025). The Impact of Allergen Avoidance in Burning Mouth Syndrome: A Case Series. [Letter to the editor]. Dermatitis. (Read full article)
    2. Westerdahl S, Hull CM, Clarke JT, Hansen CB, Rhoads JLW (2020). A single-center, retrospective record review of malignancy prevalence in patients with dermatomyositis with anti-transcription intermediary factor 1γ antibodies via line immunoassay versus immunoprecipitation. [Letter to the editor]. J Am Acad Dermatol, 84(2), 559-561. (Read full article)